Cargando…
Time to onset and duration of botulinum toxin efficacy in movement disorders
BACKGROUND: Botulinum toxin (BoNT) is a valuable treatment in movement disorders; however, time to onset and duration of efficacy may widely differ among patients. We aimed to clarify the impact of main demographic and clinical features on time to onset and duration of BoNT efficacy. METHODS: We ana...
Autores principales: | Ledda, Claudia, Artusi, Carlo Alberto, Tribolo, Antonella, Rinaldi, Domiziana, Imbalzano, Gabriele, Lopiano, Leonardo, Zibetti, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9217780/ https://www.ncbi.nlm.nih.gov/pubmed/35113259 http://dx.doi.org/10.1007/s00415-022-10995-2 |
Ejemplares similares
-
SARS-CoV-2 vaccination, Parkinson’s disease, and other movement disorders: case series and short literature review
por: Imbalzano, Gabriele, et al.
Publicado: (2022) -
How resistant are levodopa‐resistant axial symptoms? Response of freezing, posture, and voice to increasing levodopa intestinal infusion rates in Parkinson disease
por: Imbalzano, Gabriele, et al.
Publicado: (2022) -
COVID-19 in Parkinson's disease: Report on prevalence and outcome
por: Artusi, Carlo Alberto, et al.
Publicado: (2020) -
Cohort study of neurological comorbidities and COVID-19-related case fatality
por: Imbalzano, Gabriele, et al.
Publicado: (2021) -
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson’s disease
por: Montanaro, Elisa, et al.
Publicado: (2021)